Valproic Acid
Product Images NDC 67544-479

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 67544-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 250mg (67544 479)

Bottle Label 250mg (67544 479)
Valproic Acid is a medication available in the form of 250mg 90 capsules. It is recommended to store the medicine between 20-25 degrees Celsius and keep it out of the reach of children. The manufacturer of the medicine is Catalent Pharma Solutions Inc, located in St. Petersburg, FL. The medication has been repackaged by Aphena Pharma, located in Cookeville, TN. No additional information is available due to the text being partially unreadable.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Valproic 01)

FDA Label Image

Figure 1 (Valproic 02)

Figure 1 (Valproic 02)
The text describes a chart or graph showing the percentage reduction in CPS (cycles per second) rate for a medication called Divalproes sodium delayed-release tablets in comparison to a placebo. The chart also displays the percentage of patients who saw an improvement, no change, or worsening of their condition after taking the medication or placebo.*
FDA Label Image

Figure 2 (Valproic 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.